SUMMARY The serum of 893 uveitis patients was examined for various non-ocular specific autoantibodies. Overall 40.8% of patients had detectable levels of autoantibodies in their sera. These comprised antibodies to smooth muscle (23.1%), nuclear material (12.7%), gastric parietal cell (3.0%), reticulin (1.8%), and mitochondria (0-2%). When the patients were distributed into nine selected categories of uveitis, only patients with one distinct clinical entity showed a statistically significant difference in the presence of the above serum autoantibodies as compared with healthy individuals. They were patients with uveitis associated with juvenile chronic arthritis, among whom antinuclear antibody was detected in 77% (p<0-001). Testing for the presence of circulating non-ocular specific autoantibodies appears to be of little or no value in the routine screening of uveitis patients, but it may be helpful in the diagnosis and management of certain individual cases, such as juvenile chronic arthritis, or as a research tool to advance understanding of pathogenetic mechanisms.
Uveitis comprises a complex group of diseases, of which the aetiopathogenesis is often unknown. Although recent evidence reveals underlying immunological aberrations in a large number of patients,'" the exact relationship between non-ocular specific serum autoantibodies and uveitis is not clear, the literature"6 being limited and contradictory.
In view of the puzzling nature of uveitis and that it may form part of a systemic disease process, many patients are frequently overinvestigated by being subjected to a vast battery of unnecessary tests.
A large patient population was examined, therefore, to determine whether circulating non-ocular specific autoantibodies have a significant role to play in the aetiopathogenesis of uveitis. frequency tables with Yates's correction.
Materials and methods

Results
Of the 893 patients studied the majority (53%) belonged to the acute anterior uveitis category (Table 1 .)
Overall 40*8% of the patients had detectable levels of non-ocular specific autoantibodies (titre <1.50) in their serum. Although antismooth muscle antibody (ASMA) and antinuclear antibody (ANA) were the most frequently detected, 23a 1% and 12 7% respectively, patients in only one of the uveitis categories showed a statistically, significant difference in the incidence of autoantibodies as compared with healthy persons. These were patients with uveitis associated with juvenile chronic arthritis; 77% had ANA in their serum (p<O-OO1) ( Table 2) .
Discussion
Uveitis may occur as an isolated event or as a manifestation of a systemic immuno-inflammatory disease process, for example, sarcoidosis and Behcet's disease. Intraocular inflammation can develop as a result of the breakdown of regulatory immune mechanisms, which may in some cases lead to autoimmune disease involving the production of circulating autoantibodies to ocular and non-ocular structures.
The results of this study are mostly in agreement with the findings of Kijlstra et al.,6 who were unable to show any association between non-ocular specific autoantibodies and various types of uveitis. Significant associations were reported, however, by Rahi et al. ,' but the numbers of their patients were so small they were unable to draw any firm conclusions from their study. The finding of ANA in the serum of 77% of patients with juvenile chronic arthritis (p<O.OO1) is in agreement with that of previous studies.89
Recent work postulates that autoimmunity may be the result of anti-idiotypic antibodies (that is, to the shape of the antigen binding regions) of viral antibodies,'0 or occurring via mechanisms involving cross-reactive idiotypes"-for example, microorganisms or structures of a microbial agent. This may be relevant, as many infective agents have been implicated in the pathogenesis of uveitis; they include viruses,'2 chlamydia,'3 and klebsiella. ' The two stages in the generation of autoimmune disease are, first, the initiation state (that is, the development of autoantibodies or autoreactive lymphocytes), then the development of tissue damage due to immune responses. Whether the initial induction of autoreactive B and T cells leads to autoimmune disease would depend on factors such as abnormalities of the suppressor T cell pathway reported to coexist with autoimmunity and necessary to induce autoimmune disease in mice.'5 Defective suppressor T cells have been reported in acute anterior uveitis'I61 and heterochromic cyclitis,' and this defect may lead, via B cell overstimulation, not only to the production of autoreactive B and T cells but also to high levels of serum immunoglobulins and low affinity antibodies, which may be involved in immune-complex mediated inflammation. Raised levels of serum IgA'8 and circulating immune complexes24 have been found in various types of uveitis. Autoantibodies to ocular structures have also been found in uveitis. These include antibodies to retinal 'S' photoreceptor antigen,2 corneal epithelium,3 and lens crystallins (unpublished observation).
In conclusion, there seems little benefit in the routine screening of patients with uveitis for the presence of circulating non-ocular specific autoanti- 
